all report title image
  • Published In : May 2024
  • Code : CMI5085
  • Pages : 170
  • Formats :
      Excel and PDF
  • Industry : Medical Devices
Ingographics Image

The global transdermal skin patches market is estimated to be valued at USD 8.79 Bn in 2024 and is expected to exhibit a CAGR of 5.5% during the forecast period (2024-2031). The global transdermal skin patches market has been gaining traction over the past few years owing to the growing prevalence of various chronic diseases globally. Transdermal skin patches provide a convenient mode of delivery of drugs and offer several advantages over conventional drug delivery methods. These patches administer medication through the skin and into the bloodstream at a predetermined rate for an intended duration. They minimize gastric irritation caused by oral administration of drugs and provide controlled release of drug for an extended period of time. Moreover, transdermal skin patches offer non-invasive and painless delivery of drugs, which enhances patient compliance in therapy. Rising geriatric population, increasing demand for self-administration of drugs, and growing need for convenient drug delivery systems are some of the key factors anticipated to fuel the demand for transdermal skin patches in the coming years.

Market Dynamics:

Growing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, chronic pain, cancer, and neurological disorders, is a key factor boosting the adoption of transdermal skin patches globally. Moreover, the rising geriatric population who are more prone to develop chronic conditions is also augmenting the market growth. The growing preference of patients and care-givers for non-invasive and needle-free drug delivery systems owing to convenience and ease-of-use is further propelling the demand for transdermal skin patches. On the other hand, high development costs associated with transdermal patch-based drug delivery systems and regulatory challenges pertaining to clinical trials are some of the factors expected to restrain the market growth to a certain extent over the forecast period. However, ongoing advancements in formulation technologies are aimed at enhancing delivery rates of a wider range of drugs. This is expected to offer lucrative growth opportunities for players in this market.

Key Features of the Study:

  • This report provides an in-depth analysis of the global transdermal skin patches market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global transdermal skin patches market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Novartis AG, Purdue Pharma L.P., Viatris, Inc., Teikoku Pharma USA, Inc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., LUYE PHARMA AG, Samyang Holdings Corporation, Vektor Pharma, Hisamitsu Pharmaceutical Co.,Inc., UCB S.A., Hikma Pharmaceuticals PLC , Corium, Inc., Nitto Denko Corporation, Gedeon Richter Plc., Agile Therapeutics, Amneal Pharmaceuticals LLC., Cipla, and AdhexPharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global transdermal skin patches market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transdermal skin patches market.

Detailed Segmentation-

  • By Type:
    • Single-layer Drug-in-Adhesive
    • Multi-layer Drug-in-Adhesive
    • Matrix
    • Others
  • By Application:
    • Pain Relief
    • Smoking Cessation
    • Overactive Bladder
    • Hormonal Therapy
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Novartis AG
    • Purdue Pharma L.P.
    • Viatris, Inc.
    • Teikoku Pharma USA, Inc.
    • Johnson & Johnson Services, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • LUYE PHARMA AG
    • Samyang Holdings Corporation
    • Vektor Pharma
    • Hisamitsu Pharmaceutical Co., Inc.
    • UCB S.A.
    • Hikma Pharmaceuticals PLC 
    • Corium, Inc.
    • Nitto Denko Corporation
    • Gedeon Richter Plc.
    • Agile Therapeutics
    • Amneal Pharmaceuticals LLC.
    • Cipla
    • AdhexPharma

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Manufacturer Revenue
    • Acquisitions and Partnerships Scenario
    • Product Launches/Approvals
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Transdermal Skin Patches Market - Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the Market
  5. Global Transdermal Skin Patches Market, By Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Single-layer Drug-in-Adhesive
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Multi-layer Drug-in-Adhesive
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Matrix
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  6. Global Transdermal Skin Patches Market, By Application, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Pain Relief
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Smoking Cessation
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Overactive Bladder
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Hormonal Therapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  7. Global Transdermal Skin Patches Market, By Distribution Channel, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  8. Global Transdermal Skin Patches Market, By Region, 2019 – 2031, (USD Bn)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Region, 2019–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Company Profiles
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Purdue Pharma L.P.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Viatris, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Teikoku Pharma USA, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson Services, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • LUYE PHARMA AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Samyang Holdings Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Vektor Pharma
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hisamitsu Pharmaceutical Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • UCB S.A.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hikma Pharmaceuticals PLC 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Corium, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Nitto Denko Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Gedeon Richter Plc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Agile Therapeutics
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Amneal Pharmaceuticals LLC.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Cipla
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AdhexPharma
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  10. Analyst View
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 28 market data tables and 25 figures on "Transdermal Skin Patches Market” - Global forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo